US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-01 07:06:59 Source：World Weaver news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
- Alicia Keys, Brian d’Arcy James, Daniel Radcliffe and more react to earning Tony Award nominations
- Florida cops arrest man for broad daylight, on
- Israel gave US last
- Francisco Lindor slugs tiebreaking 2
- U.S. and Mexico will boost deportation flights and enforcement to crack down on illegal migration
- Sarah Nurse scores in OT to lift Toronto over Montreal 3
- Brentford routs Luton 5
- 2 Japanese navy helicopters carrying 8 crew believed crashed in Pacific, Defense Ministry says
- California's population grew in 2023, halting 3 years of decline
- What's in the $95 billion foreign
- Malian army says it killed an Islamic State group commander who attacked U.S., Niger forces
- War, hostages, antisemitism: A somber backdrop to this year's Passover observances
- Third temporary channel opens for vessels to Baltimore port after bridge collapse
- Israel gave US last
- India recalls Rishabh Pant for T20 World Cup after near
- What's in the $95 billion foreign
- Avs forward Jonathan Drouin out with lower
- Man who set himself on fire outside Trump hush money trial dies
- A Yellowstone trip that ended with a man being arrested for kicking a bison
- Ukrainian president orders demobilization of conscripts
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,World Weaver news portal sitemap